Gene expression levels of CPT1A and SREBP-1c remained higher than in NW subjects during the whole intervention period, suggesting that they reflect deeper alterations in humans with overweight and obesity, which are not easily recovered by body fat loss. This evidence concerns the gene CPT1A and obesity due to melanocortin 4 receptor deficiency.